Adia Nutrition Reports Over 200% Quarterly Revenue Growth and Advances Toward Nasdaq Listing

Reuters
2025/11/05
<a href="https://laohu8.com/S/ADIA">Adia Nutrition</a> Reports Over 200% Quarterly Revenue Growth and Advances Toward Nasdaq Listing

Adia Nutrition Inc. (OTCQB: ADIA) announced key business updates and financial results, highlighting significant growth and strategic progress in 2025. The company reported a revenue surge exceeding 200% quarter-over-quarter in the third quarter, with profit margins above 20%, attributed to strong demand for Adia Med clinics and Adia Labs regenerative products. Adia Nutrition has tripled its sales force and established four regional divisions to enhance nationwide and international distribution. The company also completed the divestiture of its non-core coffee subsidiary, Biolete Coffee, retaining an 18% equity stake. Additionally, Adia Nutrition is preparing to file its SEC Form 10 registration statement by the end of November 2025, aiming for full effectiveness by late January 2026 as part of its strategy to secure a Nasdaq listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 273008) on November 05, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10